Full-Time
Posted on 2/19/2025
Monitors and treats chronic metabolic diseases
$190k - $210kAnnually
Senior
Remote in USA
You match the following Twin Health's candidate preferences
Employers are more likely to interview you if you match these preferences:
Twin Health focuses on addressing chronic metabolic diseases by targeting their root cause: damaged metabolism. The company operates in the healthcare and wellness market, specifically for individuals suffering from conditions like diabetes and Metabolic Syndrome. Twin Health's main product is the Whole Body Digital Twin technology, which uses sensors, artificial intelligence, and digital twin technology to create a virtual model of a person's body. This system monitors and analyzes metabolic functions in real-time, allowing for personalized treatment plans to help heal damaged metabolism. Unlike its competitors, Twin Health emphasizes a subscription-based model that provides continuous support and updates to clients, ensuring they receive ongoing care. The goal of Twin Health is to reverse and prevent chronic metabolic diseases, improving the health and well-being of millions affected by these conditions.
Company Size
501-1,000
Company Stage
Late Stage VC
Total Funding
$227.1M
Headquarters
Mountain View, California
Founded
2018
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Parental Leave
Health Savings Account/Flexible Spending Account
Company Equity
Remote Work Options
Flexible Work Hours
Join Twin Health as a Salesforce Developer - India.
In order to help people lose and maintain their weight, while also getting them off of these medications, Twin Health unveiled a new program on Wednesday called Healthy Weight to address the challenge of weight loss and obesity.
Unveiling Twin Health's evolution with Lisa Shah.
Silicon Valley-based AI-powered, personalised healthcare platform Twin Health has secured $50 million in funding.
Twin Health raises $50M to target chronic metabolic disease.